PRUEBA PARA LA DETERMINACIÓN CUANTITATIVA DE LA TIROXINA TOTAL (TT4) CIRCULANTE EN SUERO O PLASMA HUMANO
Mexico·Clase I·III. Agentes de
diagnóstico·DRPRO MED S.A. DE C.V.·Registered April 29, 2024- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- TOTAL THYROXINE (CLIA) - WONDFO.
- Trade Name (English)
- TOTAL THYROXINE (CLIA) - WONDFO.
- Analysis ID
- 1223R2024 SSA
- Registration Date
- April 29, 2024
- Name (Spanish)
- DRPRO MED S.A. DE C.V.
- Name (English)
- DRPRO MED S.A. DE C.V.
Access comprehensive regulatory information for PRUEBA PARA LA DETERMINACIÓN CUANTITATIVA DE LA TIROXINA TOTAL (TT4) CIRCULANTE EN SUERO O PLASMA HUMANO (PRUEBA PARA LA DETERMINACIÓN CUANTITATIVA DE LA TIROXINA TOTAL (TT4) CIRCULANTE EN SUERO O PLASMA HUMANO) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1223R2024 SSA and manufactured by DRPRO MED S.A. DE C.V.. The device was registered on April 29, 2024.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.